The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Ketamine and the next generation of antidepressants with a rapid onset of action
Open accessAbstract
Existing treatments for major depressive disorder (MDD) usually take weeks to months to achieve their antidepressant effects, and a significant number of patients do not have adequate improvement even after months of treatment. In addition, increased risk of suicide attempts is a major public health concern during the first month of standard antidepressant therapy. Thus, improved therapeutics that can exert their antidepressant effects within hours or a few days of their administration are urgently needed, as is a better understanding of the presumed mechanisms associated with these rapid antidepressant effects. In this context, the N-methyl-D-aspartate (NMDA) antagonist ketamine has consistently shown antidepressant effects within a few hours of its administration. This makes it a valuable research tool to identify biomarkers of response in order to develop the next generation of fast-acting antidepressants. In this review, we describe clinical, electrophysiological, biochemical, and imaging correlates as relevant targets in the study of the antidepressant response associated with ketamine, and their implications for the development of novel, fast-acting antidepressants. We also review evidence that alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) to NMDA throughput may represent a convergent mechanism for the rapid antidepressant actions of ketamine. Overall, understanding the molecular basis of this work will likely lead to the ultimate development of improved therapeutics for MDD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643 · cited 2×
“Furthermore, despite the relatively large number of antidepressants available (Rush et al., 2006; Trivedi et al., 2006), our limited understanding of both the pathophysiology of MDD and the mechanisms of action involved in the therapeutic effects of antidepressants have been significant impediments to developing impro…”
BackgroundDeep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 2×
“A consistent association between increased subgenual cingulate (Cg25) activity and acute sadness has also been noted using positron emission tomography (PET); in this study, application of chronic deep brain stimulation (DBS) close to the subgenual cingulate region (Brodmann’s area 25) reduced the elevated activity in…”
BackgroundTrivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 3×
“Furthermore, despite the relatively large number of antidepressants available (Rush et al., 2006; Trivedi et al., 2006), our limited understanding of both the pathophysiology of MDD and the mechanisms of action involved in the therapeutic effects of antidepressants have been significant impediments to developing impro…”
BackgroundAntidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Self-citationAMPA Receptor Trafficking and Synaptic Plasticity
Malinow, R., & Malenka, R. C. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142758 · Cited by 2,588
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Stress, Depression, and Neuroplasticity: A Convergence of Mechanisms
Pittenger, C., & Duman, R. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301574 · Cited by 1,795
Moghaddam, B., Adams, B., Verma, A., & Daly, D. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02921.1997 · Cited by 1,793
Maeng, S., Zarate, C. A., Du, J., Schloesser, R. J., McCammon, J., Chen, G., & Manji, H. K. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.05.028 · Cited by 1,103
Self-citationCingulate function in depression: a potential predictor of treatment response
Mayberg, H. S., Brannan, S. K., Mahurin, R. K., Jerabek, P. A., Brickman, J. S., Tekell, J. L., Silva, J. A., McGinnis, S., Glass, T. G., Martin, C. C., et al. (1997) · NeuroReport · doi:10.1097/00001756-199703030-00048 · Cited by 1,029
Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders
Sanacora, G., Zarate, C. A., Krystal, J. H., & Manji, H. K. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2462 · Cited by 894
Self-citationThe role of the hippocampus in the pathophysiology of major depression
Campbell, S., & MacQueen, G. (2004) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0441 · Cited by 880
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.9.1561 · Cited by 868
Kessler, R. C., Akiskal, H. S., Ames, M., Birnbaum, H., Greenberg, P., .A, R. M., Jin, R., Merikangas, K. R., Simon, G. E., & Wang, P. S. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.9.1561 · Cited by 868
Hasler, G., van der Veen, J. W., Tumonis, T., Meyers, N., Shen, J., & Drevets, W. C. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.2.193 · Cited by 846
Subtype-Specific Alterations of γ-Aminobutyric Acid and Glutamatein Patients With Major Depression
Sanacora, G., Gueorguieva, R., Epperson, C. N., Wu, Y.-T., Appel, M., Rothman, D. L., Krystal, J. H., & Mason, G. F. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.7.705 · Cited by 796
Functional antagonists at the NMDA receptor complex exhibit antidepressant actions
Trullas, R., & Skolnick, P. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90204-j · Cited by 785
Choudary, P. V., Molnar, M., Evans, S. J., Tomita, H., Li, J. Z., Vawter, M. P., Myers, R. M., Bunney, W. E., Akil, H., Watson, S. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507901102 · Cited by 652
Pizzagalli, D., Pascual-Marqui, R. D., Nitschke, J. B., Oakes, T. R., Larson, C. L., Abercrombie, H. C., Schaefer, S. M., Koger, J. V., Benca, R. M., & Davidson, R. J. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.405 · Cited by 630 · cited 1×
“Similarly, patients with better antidepressant response to nortriptyline also had hyperactivity (higher theta activity) in the rostral ACC (Brodmann’s area 24/32), thus supporting the role of ACC activation as a predictor of antidepressant response (Pizzagalli et al., 2001).”
Increased Levels of Glutamate in Brains from Patients with Mood Disorders
Hashimoto, K., Sawa, A., & Iyo, M. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.03.017 · Cited by 609
Preskorn, S. H., Baker, B., Kolluri, S., Menniti, F. S., Krams, M., & Landen, J. W. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31818a6cea · Cited by 518
Manji, H. K., Quiroz, J. A., Sporn, J., Payne, J. L., Denicoff, K., A. Gray, N., Zarate, C. A., & Charney, D. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00117-3 · Cited by 505
Self-citationQuantitative studies on some antagonists of N‐methyl D‐aspartate in slices of rat cerebral cortex
Harrison, N. L., & Simmonds, M. A. (1985) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1985.tb12922.x · Cited by 485
Garcia, L. S. B., Comim, C. M., Valvassori, S. S., Réus, G. Z., Barbosa, L. M., Andreazza, A. C., Stertz, L., Fries, G. R., Gavioli, E. C., Kapczinski, F., et al. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.07.027 · Cited by 454
Green, S. M., Rothrock, S. G., Lynch, E. L., Ho, M., Harris, T., Hestdalen, R., Hopkins, G. A., Garrett, W., & Westcott, K. (1998) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(98)70226-4 · Cited by 410
Glutamate and Depression: Clinical and Preclinical Studies
PAUL, I. A., & SKOLNICK, P. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.016 · Cited by 408 · cited 1×
“There is also evidence that AMPA receptors appear to respond to chronic treatment with standard antidepressants (Paul & Skolnick, 2003), but the mechanisms involved seem be unrelated to those associated with ketamine’s rapid onset of antidepressant effects.”
BackgroundAntidepressants for the new millennium
Skolnick, P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00330-1 · Cited by 355
Chen, C.-H., Ridler, K., Suckling, J., Williams, S., Fu, C. H. Y., Merlo-Pich, E., & Bullmore, E. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.09.018 · Cited by 354 · cited 1×
“A recent functional MRI study found that faster improvement of depressive symptoms with fluoxetine was predicted by more positive functional activation of the ACC during the face emotional task (Chen et al., 2007).”
BackgroundCorrelation between plasma levels of glutamate, alanine and serine with severity of depression
Mitani, H., Shirayama, Y., Yamada, T., Maeda, K., Ashby, C. R., & Kawahara, R. (2006) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2006.03.036 · Cited by 332
Wu, J., Buchsbaum, M. S., Gillin, J. C., Tang, C., Cadwell, S., Wiegand, M., Najafi, A., Klein, E., Hazen, K., & Bunney, W. E. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.8.1149 · Cited by 326
Sinner, B., & Graf, B. M. (2008) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-74806-9_15 · Cited by 313
Deakin, J. F. W., Lees, J., McKie, S., Hallak, J. E. C., Williams, S. R., & Dursun, S. M. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.37 · Cited by 311
Thase, M. E., Haight, B. R., Richard, N., Rockett, C. B., Mitton, M., Modell, J. G., VanMeter, S., Harriett, A. E., & Wang, Y. (2005) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v66n0803 · Cited by 304
A Causal Role for Brain-Derived Neurotrophic Factor in the Homeostatic Regulation of Sleep
Faraguna, U., Vyazovskiy, V. V., Nelson, A. B., Tononi, G., & Cirelli, C. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.5510-07.2008 · Cited by 300
Salvadore, G., Cornwell, B. R., Colon-Rosario, V., Coppola, R., Grillon, C., Zarate, C. A., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.014 · Cited by 277 · cited 3×
“This issue is particularly interesting because synaptic potentiation is thought to be involved in ketamine’s acute antidepressant effects (Salvadore et al., 2008).”
BackgroundSelf-citationPapp, M., & Moryl, E. (1994) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)90516-9 · Cited by 272
Entsuah, A. R., Huang, H., & Thase, M. E. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n1106 · Cited by 245
Patterns of use and harms associated with non-medical ketamine use
Dillon, P. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00243-0 · Cited by 245
Plasma and platelet excitatory amino acids in psychiatric disorders
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.11.1731 · Cited by 243
Glutamatergic systems in Alzheimer's disease
Francis, P. T. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.934 · Cited by 242
Increased cerebrospinal fluid glutamine levels in depressed patients
Levine, J., Panchalingam, K., Rapoport, A., Gershon, S., McClure, R. J., & Pettegrew, J. W. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00284-x · Cited by 240 · cited 2×
“However, the rapid turnover between glutamate and glutamine, as well as the current lack of replication and contradictory findings in this area have limited our understanding of the potential role of glutamatergic biomarkers in the pathophysiology of MDD (Altamura, Maes, Dai, & Meltzer, 1995; Cortese & Phan, 2005; Fra…”
BackgroundThe Role of Glutamate in Anxiety and Related Disorders
Cortese, B. M., & Phan, K. L. (2005) · CNS Spectrums · doi:10.1017/s1092852900010427 · Cited by 232
Mauri, M. C., Ferrara, A., Boscati, L., Bravin, S., Zamberlan, F., Alecci, M., & Invernizzi, G. (1998) · Neuropsychobiology · doi:10.1159/000026491 · Cited by 231
Maeng, S., & Zarate, C. A. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0063-1 · Cited by 229
Self-citationPhenylethanolamines inhibit NMDA receptors by enhancing proton inhibition
Mott, D. D., Doherty, J. J., Zhang, S., Washburn, M. S., Fendley, M. J., Lyuboslavsky, P., Traynelis, S. F., & Dingledine, R. (1998) · Nature Neuroscience · doi:10.1038/3661 · Cited by 224
Saxena, S., Brody, A. L., Ho, M. L., Zohrabi, N., Maidment, K. M., & Baxter, L. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.3.522 · Cited by 210
Du, J., Suzuki, K., Wei, Y., Wang, Y., Blumenthal, R., Chen, Z., Falke, C., Zarate, C. A., & Manji, H. K. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301178 · Cited by 208
Self-citationSignaling: cellular insights into the pathophysiology of bipolar disorder
Manji, H. K., & Lenox, R. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)00929-x · Cited by 207
Machado-Vieira, R., Salvadore, G., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2008) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v69n0610 · Cited by 195
Self-citationAltamura, C., Maes, M., Dai, J., & Meltzer, H. Y. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(95)00033-l · Cited by 193
Increased serum glutamate in depressed patients
Kim, J. S., Schmid-Burgk, W., Claus, D., & Kornhuber, H. H. (1982) · Archiv f�r Psychiatrie und Nervenkrankheiten · doi:10.1007/bf00345492 · Cited by 189
Phelps, L. E., Brutsche, N., Moral, J. R., Luckenbaugh, D. A., Manji, H. K., & Zarate, C. A. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.029 · Cited by 189
Self-citationSmall-Dose Ketamine Improves the Postoperative State of Depressed Patients
Kudoh, A., Takahira, Y., Katagai, H., & Takazawa, T. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200207000-00020 · Cited by 189
Maes, M., Verkerk, R., Vandoolaeghe, E., Lin, A., & Scharpé, S. (1998) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1998.tb10004.x · Cited by 179
In vivo 1 H‐[ 13 C]‐NMR spectroscopy of cerebral metabolism
de Graaf, R. A., Mason, G. F., Patel, A. B., Behar, K. L., & Rothman, D. L. (2003) · NMR in Biomedicine · doi:10.1002/nbm.847 · Cited by 166
ZARATE, C. A., DU, J., QUIROZ, J., GRAY, N. A., DENICOFF, K. D., SINGH, J., CHARNEY, D. S., & MANJI, H. K. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.017 · Cited by 164
Self-citationDu, J., Gray, N. A., Falke, C. A., Chen, W., Yuan, P., Szabo, S. T., Einat, H., & Manji, H. K. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.1258-04.2004 · Cited by 157 · cited 3×
“Intriguingly, both ketamine and standard monoaminergic antidepressants seem to act directly at the NMDA and AMPA receptors (Du et al., 2004; Du et al., 2007; Maeng et al., 2008); however, it appears that ketamine’s glutamatergic targets may rapidly activate early neuroplastic changes and synaptic…”
BackgroundPotential Antidepressive Properties of Amantadine, Memantine and Bifemelane
Moryl, E., Danysz, W., & Quack, G. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01351.x · Cited by 156
Machado-Vieira, R., Yuan, P., Brutsche, N., DiazGranados, N., Luckenbaugh, D., Manji, H. K., & Zarate, C. A. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04659 · Cited by 155
Self-citationNudmamud‐Thanoi, S., & Reynolds, G. P. (2004) · Neuroscience Letters · doi:10.1016/j.neulet.2004.09.035 · Cited by 150
Low Cerebrospinal Fluid Glutamate and Glycine in Refractory Affective Disorder
Frye, M. A., Tsai, G. E., Huggins, T., Coyle, J. T., & Post, R. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.01.024 · Cited by 149
AMPA receptor subunit 1 (GluR‐A) knockout mice model the glutamate hypothesis of depression
Chourbaji, S., Vogt, M. A., Fumagalli, F., Sohr, R., Frasca, A., Brandwein, C., Hörtnagl, H., Riva, M. A., Sprengel, R., & Gass, P. (2008) · The FASEB Journal · doi:10.1096/fj.08-106450 · Cited by 144
Petrakis, I. L., Limoncelli, D., Gueorguieva, R. V., Jatlow, P. L., Boutros, N. N., Trevisan, L. A., Gelernter, J. E., & Krystal, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/ajp.161.10.1776 · Cited by 143
Current perspectives on the development of non-biogenic amine-based antidepressants
Skolnick, P., Legutko, B., Li, X., & Bymaster, F. P. (2001) · Pharmacological Research · doi:10.1006/phrs.2000.0806 · Cited by 140
Karasawa, J.-I., Shimazaki, T., Kawashima, N., & Chaki, S. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.032 · Cited by 133
NMDA Receptor Antagonism and the Ethanol Intoxication Signal
Krystal, J. H., Petrakis, I. L., Krupitsky, E. M., Schütz, C., Trevisan, L. A., & D’Souza, D. C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.010 · Cited by 132
Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder
Scarr, E., Pavey, G., Sundram, S., Mackinnon, A. J., & Dean, B. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00024.x · Cited by 130
Schumann, G., Johann, M., Frank, J., Preuss, U. W., Dahmen, N., Laucht, M., Rietschel, M., Rujescu, D., Lourdusamy, A., Clarke, T., et al. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.826 · Cited by 126
Beneyto, M., & Meador‐Woodruff, J. H. (2006) · Synapse · doi:10.1002/syn.20329 · Cited by 124
Silvestre, J. S., Nadal, R. A., S, M. A. P., & Ferr�, N. (1997) · Depression and Anxiety · doi:10.1002/(sici)1520-6394(1997)5:1<29::aid-da5>3.0.co;2-0 · Cited by 116
Przegaliński, E., Tatarczynska, E., Dereń-Wesołek, A., & Chojnacka-Wójcik, E. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(96)00157-8 · Cited by 112
Open channel block of NMDA receptor responses evoked by tricyclic antidepressants
Sernagor, E., Kuhn, D. M., Vyklický, L., & Mayer, M. L. (1989) · Neuron · doi:10.1016/0896-6273(89)90306-1 · Cited by 110
Kristiansen, L. V., & Meador‐Woodruff, J. H. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.012 · Cited by 108
Zarate, C. A., Quiroz, J. A., Quiroz, J. A., Manji, H. K., Payne, J. L., Kornstein, S. G., Manji, A. H. K., & MD (2025) · Psychopharmacology Bulletin · doi:10.64719/pb.4204 · Cited by 105
Self-citationA Brief Overview of the Clinical Pharmacology of “Club Drugs”
Britt, G. C., & McCance‐Katz, E. F. (2005) · Substance Use & Misuse · doi:10.1081/ja-200066730 · Cited by 99
Dizocilpine antagonizes the effect of chronic imipramine on learned helplessness in rats
Meloni, D., Gambarana, C., Montis, M. G. D., Pra, P. D., Taddei, I., & Tagliamonte, A. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90374-3 · Cited by 96
McCormick, L. M., Ponto, L. L. B., Pierson, R. K., Johnson, H. J., Magnotta, V. A., & Brumm, M. C. (2007) · Journal of Ect · doi:10.1097/yct.0b013e318150d56d · Cited by 89
Baune, B. T., Adrian, I., & Jacobi, F. (2007) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2006.09.014 · Cited by 89
Antidepressant-like effects of NMDA-receptor antagonist injected into the dorsal hippocampus of rats
Padovan, C. M., & Guimarães, F. S. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.09.015 · Cited by 83
Aguado, L., Antonio, A. S., Pérez, L., del Valle, R., & Gómez, J. (1994) · Behavioral and Neural Biology · doi:10.1016/s0163-1047(05)80010-x · Cited by 82
Antidepressant Effect of Ketamine During ECT
Ostroff, R. B., GONZALES, M., & Sanacora, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1385 · Cited by 82
Papp, M., & Moryl, E. (1996) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00675-9 · Cited by 81
Ethanol-related behaviors in mice lacking the NMDA receptor NR2A subunit
Boyce‐Rustay, J. M., & Holmes, A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0448-6 · Cited by 79
Skolnick, P., Miller, R. L., Young, A. J., Boje, K. M. K., & Trullás, R. (1992) · Psychopharmacology · doi:10.1007/bf02245261 · Cited by 78
Maj, J., Rogóż, Z., Skuza, G., & Sowińska, H. (1992) · PubMed · Cited by 78
Pittaluga, A., Raiteri, L., Longordo, F., Luccini, E., Barbiero, V. S., Racagni, G., Popoli, M., & Raiteri, M. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.04.006 · Cited by 77
Correll, G. E., & Futter, G. E. (2006) · Pain Medicine · doi:10.1111/j.1526-4637.2006.00101.x · Cited by 73
Repeated intravenous ketamine therapy in a patient with treatment-resistant major depression
Liebrenz, M., Stohler, R., & Borgeat, A. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970701420481 · Cited by 73
Langguth, B., Wiegand, R., Kharraz, A., Landgrebe, M., Marienhagen, J., Frick, U., Hajak, G., & Eichhammer, P. (2007) · PubMed · Cited by 68
Goforth, H. W., & Holsinger, T. (2007) · Journal of Ect · doi:10.1097/01.yct.0000263257.44539.23 · Cited by 63
Petrenko, A. B., Yamakura, T., Fujiwara, N., Askalany, A. R., Baba, H., & Sakimura, K. (2004) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000131729.54986.30 · Cited by 53
Papp, M., & Moryl, E. (1993) · PubMed · Cited by 51
Payne, J. L., Quiroz, J. A., Zarate, C. A., & Manji, H. K. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01676-1 · Cited by 46
Self-citationKetamine blocks a conditioned taste aversion (CTA) in neonatal rats1
Mickley, G. A., Schaldach, M. A., Snyder, K. J., Balogh, S. A., Len, T., Neimanis, K., Goulis, P., Hug, J., Sauchak, K., Remmers-Roeber, D. R., et al. (1998) · Physiology & Behavior · doi:10.1016/s0031-9384(98)00097-3 · Cited by 44
Matrisciano, F., Scaccianoce, S., Bianco, P. D., Panaccione, I., Canudas, A. M., Battaglia, G., Riozzi, B., Ngomba, R. T., Molinaro, G., Tatarelli, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03141.x · Cited by 33
Kessal, K., Chessel, A., Spennato, G., & Garcia, R. (2005) · Synapse · doi:10.1002/syn.20154 · Cited by 17
Cited by
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723
Inflammation, glutamate, and glia: a trio of trouble in mood disorders
Haroon, E., Miller, A. H., & Sanacora, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.199 · Cited by 584
Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00670-0 · Cited by 492
The kynurenine pathway and the brain: Challenges, controversies and promises
Schwarcz, R., & Stone, T. W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.003 · Cited by 461
Zhou, W., Wang, N., Yang, C., Li, X.-M., Zhou, Z.-Q., & Yang, J.-J. (2014) · European Psychiatry · doi:10.1016/j.eurpsy.2013.10.005 · Cited by 390
“Unfortunately, the delayed onset time and the low remission rate of these conventional antidepressants are still major challenges [16,10].”
Background
Metadata
- Authors
- Machado-Vieira, R., Salvadore, G., DiazGranados, N., & Zarate, C. A.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-08
- Volume
- 123
- Issue
- 2
- Pages
- 143-150
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2027572751
- Cited by
- 276
- References
- 97
- FWCI
- 16.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.